PapersPMID:19242554
Creatine fails to augment the benefits from resistance training in patients with HIV infection: a randomized, double-blind, placebo-controlled study.
creatineWhat moved
1 findingHow to read these marks →- Increases triglycerides
moderate
“Triglycerides increased with creatine at week 14 (P = 0.04 vs. placebo).”
- Study
- RCT
- Duration
- 3 months
- Interests
- Industry funded
- Dose studied
- creatine monohydrate 20 g/day loading for 5 days, then 4.8 g/day, with 5-day reloading at weeks 7 and 13; each dose taken with a 20 g carbohydrate juice in both arms
- Population
- Clinically stable, sedentary HIV-positive men; thrice-weekly supervised progressive resistance training from week 2 to week 14 in both arms
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Clinically stable, sedentary HIV-positive men (42 men and 1 woman recruited; 40 underwent baseline testing), on stable antiretroviral therapy or none; creatine monohydrate versus placebo during progressive resistance training
- Participants
- 40
- Comparator
- placebo
- Duration
- 98 days
- Endpoints measured
- 103